Elena‐Laura Antohi

ORCID: 0000-0002-8718-0133
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Heart Failure Treatment and Management
  • Cardiovascular Function and Risk Factors
  • Cardiac Structural Anomalies and Repair
  • Cardiac Valve Diseases and Treatments
  • Mechanical Circulatory Support Devices
  • Infective Endocarditis Diagnosis and Management
  • Cardiac pacing and defibrillation studies
  • Cardiac electrophysiology and arrhythmias
  • Cardiac Imaging and Diagnostics
  • Diabetes Treatment and Management
  • Cardiac Arrest and Resuscitation
  • Acute Myocardial Infarction Research
  • Iron Metabolism and Disorders
  • Metabolism, Diabetes, and Cancer
  • Atrial Fibrillation Management and Outcomes
  • Cardiac Arrhythmias and Treatments
  • Cardiovascular Health and Disease Prevention
  • Erythropoietin and Anemia Treatment
  • Healthcare Systems and Technology
  • Pancreatic function and diabetes
  • Aortic Disease and Treatment Approaches
  • Cardiac tumors and thrombi
  • Social Media in Health Education
  • Aortic Thrombus and Embolism
  • Telemedicine and Telehealth Implementation

Carol Davila University of Medicine and Pharmacy
2017-2024

Institutul de Urgenţă pentru Boli Cardiovasculare "Prof.Dr. C.C. Iliescu"
2018-2024

Advanced Neural Dynamics (United States)
2020

Right‐sided heart failure and tricuspid regurgitation are common strongly associated with poor quality of life an increased risk hospitalizations death. While medical therapy for right‐sided is limited, treatment options include surgery and, based on recent developments, several transcatheter interventions. However, the patients who might benefit from valve interventions yet unknown, as ideal time these treatments given paucity clinical evidence. In this context, it crucial to elucidate...

10.1002/ejhf.3106 article EN cc-by-nc European Journal of Heart Failure 2023-12-22

Acute Heart Failure (AHF) is a " multi-event disease" and hospitalisation critical event in the clinical course of HF. Despite relatively rapid relief symptoms, for AHF followed by an increased risk death re-hospitalisation. In AHF, stratification from clinically available data increasingly important evaluating long-term prognosis. From perspective patients, information on mortality re-hospitalisation would be helpful providing patients with insight into their disease. care providers, it may...

10.15420/cfr.2017:12:1 article EN Cardiac failure review 2017-01-01

Left ventricular ejection fraction (LVEF) and ventricular-arterial coupling (VAC) [VAC = Ea/Ees; Ea: effective arterial elastance; Ees: left ventricle (LV) elastance] are both dimensionless ratios with important limitations, especially in heart failure setting. The LVEF to VAC relationship is a divergent non-linear function, having point of intersection at the specific value 0.62, where V0 0 ml (V0: theoretical extrapolated volume-axis intercept end-systolic pressure mmHg). For dilated LV,...

10.3389/fcvm.2021.750965 article EN cc-by Frontiers in Cardiovascular Medicine 2022-01-21

Abstract Aims Sodium‐glucose cotransporter type 2 inhibitors (SGLT‐2i) represent a unique class of anti‐hyperglycaemic agents for diabetes mellitus that selectively inhibit renal glucose reabsorption, thereby increasing urinary excretion glucose. Several studies have demonstrated the cardioprotective effects SGLT‐2i in patients with heart failure (HF), unrelated to its glucosuric effect. It is unclear whether benefits therapy also rely on improvement left ventricular (LV) and/or right (RV)...

10.1002/ehf2.14331 article EN cc-by-nc-nd ESC Heart Failure 2023-03-15

Left ventricular ejection fraction is the critical parameter used for heart failure classification, decision making and assessing prognosis. It defined as a volumetric ratio essentially composite of arterial elastances, but not intrinsic contractility. The clinician should be aware its numerous limitations when measuring reporting it. And make step toward more insightful understanding hemodynamics.

10.37349/emed.2020.00006 article EN cc-by Exploration of Medicine 2020-04-30

Abstract Tachycardiomyopathy, characterized by ventricular systolic dysfunction resulting from persistent tachycardia, poses a significant challenge in cardiovascular disease management. This article presents the case of 31-year-old male patient with dilated cardiomyopathy and recurrent atrial fibrillation, admitted due to heart failure decompensation. Ischemic inflammatory etiologies for were ruled out prior assessments. Despite multiple antiarrhythmic drugs attempted electrical...

10.2478/rjc-2024-0002 article EN cc-by Romanian Journal of Cardiology 2024-03-01

aEmergency Institute for Cardiovascular Diseases 'C.C.Iliescu' bUniversity of Medicine and Pharmacy 'Carol Davila', Bucharest, Romania Correspondence to Elena-Laura Antohi, MD, MSc, PhD, Emergency Diseases, Prof C Iliescu, E-mail: [email protected] Received 3 March, 2024 Accepted 15

10.2459/jcm.0000000000001617 article EN Journal of Cardiovascular Medicine 2024-04-26

Abstract Background/Introduction After the pandemic, there has been a significant rise in time people dedicate to social networks. Throughout periods of local and international lockdowns, these platforms became recognized as quicker more effective tools for communication across various fields. Purpose We aimed conduct study assess effectiveness deploying an information system improve process between patients healthcare specialists. Methods A questionnaire consisting 20 questions was...

10.1093/eurjcn/zvae098.134 article EN European Journal of Cardiovascular Nursing 2024-07-01

Triple-valve replacement in active infective endocarditis has rarely been reported. This paper is the first report of a triple-valve performed with septic shock and presentation multivalvular due to Rhizobium radiobacter.A 26-year-old patient neglected ventricular septal defect referred us shock, multiple organ failure, severe biventricular dysfunction, pulmonary hypertension, radiobacter affecting aortic, tricuspid valves. Initially, he was deemed unfit for surgery. However, after clinical...

10.1016/j.ijscr.2022.107401 article EN International Journal of Surgery Case Reports 2022-07-13

Abstract Introduction : Several landmark studies, which enrolled heart failure (HF) patients who were ambulatory at the time of inclusion, identified iron deficiency (ID) as an important therapeutic target: intravenous administration with ferric carboxymaltose (FCM) improves morbidity, exercise capacity, and quality life in HF reduced EF (HFrEF). However, there is still limited knowledge about ID prevalence during hospitalization for Worsening Chronic (WCHF) relationship between...

10.2478/rrlm-2018-0022 article EN cc-by-nc-nd Revista română de medicină de laborator 2018-07-01

Abstract Background The presence of small mobile masses on the ventricular side aortic valves in absence valvular regurgitation and signs systemic inflammation has been previously described as marantic endocarditis is now referred to nonbacterial thrombotic (NBTE). It thought be associated with endothelial dysfunction procoagulative status, case acute decompensated heart failure (HF). Case description We present a series three male patients, similar clinical characteristics, who were...

10.1093/ehjci/jez319.697 article EN European Heart Journal - Cardiovascular Imaging 2020-01-01

Ejection fraction (EF) is considered to provide clinically useful information. Despite its enormous popularity, with more than 75,000 citations in PubMed, only few studies have traced the origin(s) of foundation. This fact surprising, as there are perhaps papers published that criticize EF, number publications actually a solid (mathematical) basis for alleged applicability. EF depends on two volume determinations, namely end-systolic (ESV) and end-diastolic (EDV). defined 1-ESV/EDV, yielding...

10.1109/embc48229.2022.9871315 article EN 2022 44th Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2022-07-11
Coming Soon ...